|
Alonso-Romero JL, Martinez-Garcia J, Carrillo-Vicente R, Aramburo AF, Diez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jimenez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreno PR. Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. Breast Cancer Res Treat. 2026 Jan 20;215(2):60. doi: 10.1007/s10549-026-07895-8. PubMed PMID: 41557021; PubMed Central PMCID: PMC12819485.
AÑO: 2026; IF: 3.0
|
|
Encarnación J.A., Hernández A.L., López G.L., Alonso-Romero J.L., De la Fuente Muñoz M.I., Cánovas E.C., Carreño P.R., Royo-Villanova M., Manso C. Probable chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids syndrome: management with corticosteroids and intravenous immunoglobulin—a case report. Journal of Medical Case Reports. December 2025. 19. 10.1186/s13256-025-05402-z
AÑO: 2025; IF: 0.8
|
|
Encarnación J.A., Coll E., Manso C., Llorente S., Morales F., Saura I., López-Cubillana P., Martínez-Valls P.L.G., Martínez G., De la Fuente I., Cárdenas E., Alonso-Romero J.L., Ruiz P., Moya J., Domínguez-Gil B., Royo-Villanova M. Outcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis. Medical Sciences. September 2025. 13. 10.3390/medsci13030188
AÑO: 2025; IF: 4.4
|
|
Encarnacion JA, Manso C, Royo-Villanova M, Ruiz P, De la Fuente MI, Cardenas E, Ros S, Alonso-Romero JL. Incidence and Survival of IDH-Wildtype Glioblastoma and IDH-Mutant Astrocytoma by Treatment and Sex: A Regional Study in Spain (2011-2021). Med Sci (Basel). 2025 Oct 14;13(4):233. doi: 10.3390/medsci13040233. PubMed PMID: 41133515; PubMed Central PMCID: PMC12551061.
AÑO: 2025; IF: 4.4
|
|
Encarnacion JA, Lopez-Jimenez E, Alonso-Romero JL, Ruiz P, Ros S, De la Fuente MI, Lopez F, Cardenas E, Laborda A, Sanchez-Perez M, Rodriguez C, Manso C, Ortega-Lopez ND, Lopez-Cubillana P, Guzman Martinez-Valls PL, Cao-Avellaneda E, Lopez-Gonzalez PA, Lopez-Abad A. Bone Health in Metastatic Hormone-Sensitive Prostate Cancer: Where We Stand and Where We Can Improve. Cancers (Basel). 2025 Dec 13;17(24):3977. doi: 10.3390/cancers17243977. PubMed PMID: 41463226; PubMed Central PMCID: PMC12730855.
AÑO: 2025; IF: 4.4
|
41557021